Trial Profile
A study to evaluate whether increasing regulatory T cells by tocilizumab correlates with clinical response in patients with rheumatoid arthritis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jul 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Biomarker; Therapeutic Use
- 30 Jul 2015 New trial record